Recapitulation of metabolic defects in a model of propionic acidemia using patient-derived primary hepatocytes.

[1]  A. Mackey,et al.  Transcriptional profiling suggests that Nevirapine and Ritonavir cause drug induced liver injury through distinct mechanisms in primary human hepatocytes. , 2016, Chemico-biological interactions.

[2]  Zhe Zhang,et al.  Gene expression in cell lines from propionic acidemia patients, carrier parents, and controls. , 2015, Molecular genetics and metabolism.

[3]  Adam M. Behrens,et al.  Simple and inexpensive quantification of ammonia in whole blood. , 2015, Molecular genetics and metabolism.

[4]  M. Baumgartner,et al.  The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype , 2015, Journal of Inherited Metabolic Disease.

[5]  Dave T. Gerrard,et al.  Phenotypic and functional analyses show stem cell-derived hepatocyte-like cells better mimic fetal rather than adult hepatocytes , 2015, Journal of hepatology.

[6]  R. Wanders,et al.  Inhibition of N-acetylglutamate synthase by various monocarboxylic and dicarboxylic short-chain coenzyme A esters and the production of alternative glutamate esters. , 2014, Biochimica et biophysica acta.

[7]  Anita MacDonald,et al.  Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia , 2014, Orphanet Journal of Rare Diseases.

[8]  E. Lander,et al.  Development and Applications of CRISPR-Cas9 for Genome Engineering , 2014, Cell.

[9]  P. Hayes,et al.  Profiling the Impact of Medium Formulation on Morphology and Functionality of Primary Hepatocytes in vitro , 2013, Scientific Reports.

[10]  T. Pruett,et al.  Hemodynamic flow improves rat hepatocyte morphology, function, and metabolic activity in vitro. , 2013, American journal of physiology. Cell physiology.

[11]  J. Vockley,et al.  Development of clinical guidelines for inborn errors of metabolism: commentary. , 2013, Molecular genetics and metabolism.

[12]  B. Burton,et al.  Survey of health status and complications among propionic acidemia patients , 2012, American journal of medical genetics. Part A.

[13]  V. Sutton,et al.  Chronic management and health supervision of individuals with propionic acidemia. , 2012, Molecular genetics and metabolism.

[14]  Tiina K. Urv,et al.  Natural history of propionic acidemia. , 2012, Molecular genetics and metabolism.

[15]  M. Tuchman,et al.  N-carbamylglutamate Augments Ureagenesis and Reduces Ammonia and Glutamine in Propionic Acidemia , 2010, Pediatrics.

[16]  John Wambaugh,et al.  Simulating Microdosimetry in a Virtual Hepatic Lobule , 2010, PLoS Comput. Biol..

[17]  Matthew H. M. Lim,et al.  Perfused multiwell plate for 3D liver tissue engineering. , 2010, Lab on a chip.

[18]  E. Alexandre,et al.  Isolation and culture of primary hepatocytes from resected human liver tissue. , 2010, Methods in molecular biology.

[19]  Walker Inman,et al.  Liver tissue engineering in the evaluation of drug safety , 2009, Expert opinion on drug metabolism & toxicology.

[20]  B. Lake,et al.  Induction of drug metabolism: species differences and toxicological relevance. , 2008, Toxicology.

[21]  S. Bhatia,et al.  Microscale culture of human liver cells for drug development , 2008, Nature Biotechnology.

[22]  K. Urschel,et al.  Nutritional consequences of interspecies differences in arginine and lysine metabolism. , 2007, The Journal of nutrition.

[23]  R. de Kanter,et al.  Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction , 2006, Expert opinion on drug metabolism & toxicology.

[24]  F. Santorelli,et al.  Methylmalonic and propionic aciduria , 2006, American journal of medical genetics. Part C, Seminars in medical genetics.

[25]  Thomas Tuschl,et al.  siRNAs: applications in functional genomics and potential as therapeutics , 2004, Nature Reviews Drug Discovery.

[26]  R. Groszmann,et al.  American association for the study of liver diseases , 1992 .

[27]  Silvio Albertini,et al.  Gene expression in two hepatic cell lines, cultured primary hepatocytes, and liver slices compared to the in vivo liver gene expression in rats: possible implications for toxicogenomics use of in vitro systems. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[28]  C. Pérez-Cerdá,et al.  Functional analysis of PCCB mutations causing propionic acidemia based on expression studies in deficient human skin fibroblasts. , 2003, Biochimica et biophysica acta.

[29]  R. Edwards,et al.  Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells , 2002, Xenobiotica; the fate of foreign compounds in biological systems.

[30]  T. K. Baker,et al.  Temporal gene expression analysis of monolayer cultured rat hepatocytes. , 2001, Chemical research in toxicology.

[31]  M. Schwartz,et al.  High incidence of propionic acidemia in greenland is due to a prevalent mutation, 1540insCCC, in the gene for the beta-subunit of propionyl CoA carboxylase. , 2000, American journal of human genetics.

[32]  E. Richard,et al.  Overview of mutations in the PCCA and PCCB genes causing propionic acidemia , 1999, Human mutation.

[33]  R. Maass-Moreno,et al.  Distribution of pressure gradients along hepatic vasculature. , 1997, The American journal of physiology.

[34]  G. Gascon,et al.  Unusual presentations of propionic acidemia , 1994, Brain and Development.

[35]  O. Elpeleg,et al.  Propionic acidemia--biochemical studies. , 1989, Israel journal of medical sciences.

[36]  C. Zancanaro,et al.  Differences in glucose metabolic enzyme activities in human adipose tissue from abdominal and gluteal regions. , 1988, Metabolism: clinical and experimental.

[37]  J. Varani,et al.  Substrate-dependent differences in growth and biological properties of fibroblasts and epithelial cells grown in microcarrier culture. , 1985, Journal of biological standardization.

[38]  J. Waterlow.  Protein turnover with special reference to man. , 1984, Quarterly journal of experimental physiology.

[39]  R. Chalmers,et al.  Disorders of propionate and methylmalonate metabolism , 1982 .

[40]  J. Berman,et al.  Differences between rat liver epithelial and fibroblast cells in metabolism of purines , 1980, Journal of cellular physiology.

[41]  W. Nyhan,et al.  Inhibition by propionyl-coenzyme A of N-acetylglutamate synthetase in rat liver mitochondria. A possible explanation for hyperammonemia in propionic and methylmalonic acidemia. , 1979, The Journal of clinical investigation.

[42]  E. Kun,et al.  Metabolic differences between mitochondria isolated from various tissues. , 1966, Biochemical and biophysical research communications.

[43]  H. Loh,et al.  Tissue specific differences in rate limiting factors of glutamate metabolism in enzyme systems of kidney and liver. , 1966, Biochemical and biophysical research communications.